Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Kenvue Inc. Common Stock (KVUE) vs Xpeng Inc - ADR (XPEV) Price & Performance

Kenvue Inc. Common StockTrade
Xpeng Inc - ADRTrade

Price performance (Past 24H)

Key statistics

Kenvue Inc. Common Stock vs Xpeng Inc - ADR — how do they compare? Kenvue Inc. Common Stock trades at $17.7 (market cap $34.06B), while Xpeng Inc - ADR trades at $9.9 (market cap $9.16B). The key difference: Kenvue Inc. Common Stock is far larger — about 3.7× Xpeng Inc - ADR's market cap, and Kenvue Inc. Common Stock pays a 4.74% dividend while Xpeng Inc - ADR pays none. Which is the better fit depends on your goals.

KVUEXPEV
Market Cap
$34.06B$9.16B
Volume
23,267,2285,030,325
Sector
Consumer StaplesConsumer Cyclical
52-Week High
$19.83$28.07
52-Week Low
$14.11$9.25
Enterprise Value
$41.56B$11.09B
Dividend Yield
4.74%—
Typical Hold Time
—80 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Kenvue Inc. Common Stock

No Aura AI signal available yet.

Xpeng Inc - ADR

XPeng (XPEV) trades at $9.55, down 0.31% with bearish technical signals despite analyst optimism. The company shows strong revenue growth to $76.72B in 2025 but remains unprofitable with a -$1.14B net loss. Recent vehicle deliveries of 41,256 units in September 2026 and upcoming G9L SUV launch at Paris Motor Show highlight expansion efforts. Cash flow improved significantly with $8.26B from operations in 2025, though negative earnings surprises in Q1 and Q2 2026 raise execution concerns.

XPeng presents a high-risk growth opportunity with 58.8% analyst buy ratings and $17.55 price target suggesting 84% upside. However, persistent losses, competitive EV market pressures, and technical bearishness create significant headwinds. The stock's appeal hinges on successful Physical AI and robotics commercialization alongside sustained delivery growth.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

KVUE

No sentiment data available yet.

XPEV
14% Buy86% Sell
Avg holding period · 80 Days

Top news

Latest headlines on both assets

About Kenvue Inc. Common Stock

Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.

Read more on KVUE →

About Xpeng Inc - ADR

Founded in 2015, XPeng is a leading Chinese smart electric vehicle, or EV, company that designs, develops, manufactures and markets EVs in China. Its products primarily target the growing base of technology-savvy middle-class consumers in the midrange to high-end segment in China's passenger vehicle market. The company sold over 98,000 EVs in 2021, accounting for about 3% of China's passenger new energy vehicle market. It is also a leader in autonomous driving technology.

Read more on XPEV →